Biosortia and Ross Youngs Announce Appointment of Jaime Streator to Board of Directors April 07, 2026 | By Biosortia COLUMBUS, OH, UNITED STATES, April 7, 2026 /EINPresswire.com/ — Biosortia and Founder, Ross Youngs today announced the appointment of Jaime Streator to their Board of Directors, Mr. Streator brings over four decades of deep experience in healthcare investment banking to the board, further strengthening the organizations’ strategic
Pharmaceuticals from marine sources: past, present and future An overview of why marine natural products are an attractive prospect for future drug discovery, including history of the field, successes in the clinic and challenges associated with gaining clinical approval.
What’s in store for biotech in 2023? Perhaps 2022 will best be remembered in the life science industry for the return of many of the face-to-face events that fell by the wayside during the COVID-19 pandemic.
